New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Biodesix, Inc.
BDSX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

238M

Medical - Diagnostics & Research

Next Earning date - 01 Nov 2024

238M

Medical - Diagnostics & Research

Next Earning date - 01 Nov 2024

1.64USD
Shape0.01 ( 0.61%)
favorite-chart

Relative Strenght

26
favorite-chart

Volume Buzz

-65%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

26%

Quote Panel

Shape
Updated October 26, 2024
1W 2.50 % 1M -4.09 % 3M -4.09 % 1Y 17.99 %

Key Metrics

Shape
  • Market Cap

    238.09M


  • Shares Outstanding

    145.18M


  • Share in Float

    76.49M


  • Dividende

    0


  • Earning Date

    01 Nov 2024


  • Price Target

    1.64


  • Average Volume

    149473


  • Beta

    1.214


  • Range

    1.15-2.21


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.biodesix.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.91x

P/S Ratio

5.75x

P/B Ratio

1.0

Debt/Equity

-73.1%

Net Margin

$-0.5

EPS

How BDSX compares to sector?

P/E Ratio

Relative Strength

Shape

BDSX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$90M

Shape402%

2025-Revenue

$0.24

Shape-182%

2025-EPS

$69M

Shape-906%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Scotiabank

initialise

Previous: Not converted

2024-09-16

Now: Outperform

Craig-Hallum

initialise

Previous: Not converted

2024-07-26

Now: Buy

Cowen & Co.

initialise

Previous: Not converted

2024-05-13

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.34
vs -0.50

Q4.22

arrow
arrow

N/A

-0.28
vs -0.49

Q1.23

arrow
arrow

N/A

-0.24
vs -0.50

Q2.23

arrow
arrow

N/A

-0.17
vs -0.40

Q3.23

arrow
arrow

N/A

-0.12
vs -0.34

Q4.23

arrow
arrow

N/A

-0.10
vs -0.28

Q1.24

arrow
arrow

N/A

-0.14
vs -0.24

Q2.24

arrow
arrow

N/A

-0.08
vs -0.17

Q3.24

arrow
arrow

N/A

-0.07
vs -0.12

Q4.24

arrow
arrow

N/A

-0.07
vs -0.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+70%

11.1M  vs 6.5M

Q4.22

arrow
arrow

+33%

9.6M  vs 7.2M

Q1.23

arrow
arrow

+38%

9.1M  vs 6.5M

Q2.23

arrow
arrow

+8%

11.9M  vs 10.9M

Q3.23

arrow
arrow

+21%

13.5M  vs 11.1M

Q4.23

arrow
arrow

+53%

14.7M  vs 9.6M

Q1.24

arrow
arrow

+64%

14.8M  vs 9.1M

Q2.24

arrow
arrow

+51%

17.9M  vs 11.9M

Q3.24

arrow
arrow

+38%

18.6M  vs 13.5M

Q4.24

arrow
arrow

+35%

19.9M  vs 14.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+578%

5.78
vs -2.06

Q4.22

arrow
arrow

-130%

-1.30
vs 5.78

Q1.23

arrow
arrow

-376%

-3.76
vs -1.30

Q2.23

arrow
arrow

+191%

1.91
vs -3.76

Q3.23

arrow
arrow

+757%

7.57
vs 1.91

Q4.23

arrow
arrow

-200%

-2.00
vs 7.57

Q1.24

arrow
arrow

+247%

2.47
vs -2.00

Q2.24

arrow
arrow

-30%

-0.30
vs 2.47

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

25

25
vs 36

-31%

Q4.22

arrow
arrow

34

34
vs 25

36%

Q1.23

arrow
arrow

28

28
vs 34

-18%

Q2.23

arrow
arrow

26

26
vs 28

-7%

Q3.23

arrow
arrow

37

37
vs 26

42%

Q4.23

arrow
arrow

39

39
vs 37

5%

Q1.24

arrow
arrow

42

42
vs 39

8%

Q2.24

arrow
arrow

47

47
vs 42

12%

Earnings Growth

Latest News